Received Feb 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
has stenosis in his spine and it was caused by the zoster virus/nerve pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of spinal stenosis in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (patient received 1st dose in 2020). Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX). On an unknown date, the patient received the 2nd dose of Shingrix. In OCT-2024, an unknown time after receiving Shingrix and SHINGRIX, the patient experienced spinal stenosis (Verbatim: has stenosis in his spine and it was caused by the zoster virus/nerve pain). The outcome of the spinal stenosis was not reported. The reporter considered the spinal stenosis to be related to Shingrix. The company considered the spinal stenosis to be related to Shingrix. Additional Information: GSK receipt date: 16-JAN-2025 The reporter was the patient. Patient stated that he had the complete series of Shingrix administer with the first dose in 2020 and the second dose in 2021. the patient stated he started experiencing nerve pain in October 2024. Also, states his doctor said he had stenosis in his spine and it was caused by the zoster virus. Consumer denied having been diagnosis with shingles. No further information was known including dates of administration of Shingrix, demographics of consumer.
SHINGRIX